FindMyRecallSubscribe
Class II: temporary or reversible health riskCompleted

Slate Run Pharmaceuticals Cinacalcet Hydrochloride Tablets 30 mg Recall

Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr

Slate Run Pharmaceuticals · Columbus, OH

Risk level
Class II
Reported by FDA
Mar 26, 2025
Recall ID
D-0278-2025
Check your lot numberHow we source this data

Summary

Slate Run Pharmaceuticals recalled Cinacalcet Hydrochloride Tablets 30 mg starting Mar 7, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0278-2025 on Mar 26, 2025. Reason: CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits. Status: Completed.

Why it was recalled

CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.

Product description

Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04

Lot numbers, UPCs & expiration codes

Lot # 07711, Exp 07/2025; 08900, Exp 09/2026; 08899, Exp 09/2026

Where it was sold

Product was distributed to 8 distributors who may have further distribute the product nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0278-2025
Classification
Class II
Status
Completed
Recall initiated
Mar 7, 2025
FDA report date
Mar 26, 2025
Quantity
56,790 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Slate Run Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D-0278-2025, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Completed
Country
United States
Event ID
96433
Address
277 W Nationwide Blvd Ste 260
Code information
Lot # 07711, Exp 07/2025; 08900, Exp 09/2026; 08899, Exp 09/2026
Postal code
43215-0169
Report date
Mar 26, 2025
Product type
Drugs
Recall number
D-0278-2025
Classification
Class II
Recalling firm
Slate Run Pharmaceuticals
Product quantity
56,790 bottles
Reason for recall
CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04
Distribution pattern
Product was distributed to 8 distributors who may have further distribute the product nationwide.
Recall initiation date
Mar 7, 2025
Initial firm notification
Letter
Center classification date
Mar 17, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0278-2025, published Mar 26, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls